Skip to main content
. Author manuscript; available in PMC: 2019 Sep 9.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2019 Apr 10;4(7):545–558. doi: 10.1016/S2468-1253(19)30119-0

Figure 3: Mechanisms of CD8+ T-cell failure and potential targets for curative immunotherapeutic approaches in the setting of chronic hepatitis B.

Figure 3:

HBsAg=hepatitis B surface antigen. IL=interleukin. MDSC=myeloid-derived suppressor cells. NK=natural killer. TCR=T-cell receptor. TGF=transforming growth factor.